HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
Saved in:
| Title: | HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens. |
|---|---|
| Authors: | Shen X; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA. sxshen@duke.edu., Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., McMillan AS; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Spreng RL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Yates NL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Juliana McElrath M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Allen M; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Pensiero M; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Mehra VL; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Der Meeren OV; GSK Vaccines, Rixensart, Belgium., Barnett SW; GSK Vaccines (formerly Novartis Vaccines), Cambridge, Massachusetts, USA.; Bill & Melinda Gates Foundation, Seattle, Washington, USA., Phogat S; Sanofi Pasteur, Swiftwater, Pennsylvania, USA., Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; South African Medical Research Council, Cape Town, South Africa., Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Tomaras GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu. |
| Source: | Scientific reports [Sci Rep] 2020 Feb 07; Vol. 10 (1), pp. 2093. Date of Electronic Publication: 2020 Feb 07. |
| Publication Type: | Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
